|
|
|
|
| LEADER |
00883nam a2200241 a 4500 |
| 001 |
1769393 |
| 005 |
20171111234518.0 |
| 008 |
020404s2001 sz sb i000 0 eng d |
| 020 |
|
|
|z 924154547X
|
| 040 |
|
|
|a CaPaEBR
|
| 050 |
1 |
4 |
|a RA401.A1
|b H69 2001eb
|
| 240 |
1 |
0 |
|a Guidelines for developing national drug policies
|
| 245 |
0 |
0 |
|a How to develop and implement a national drug policy
|
| 246 |
1 |
|
|a Guidelines for developing national drug policies
|
| 250 |
|
|
|a 2nd ed.
|
| 260 |
|
|
|a Geneva :
|b World Health Organization,
|c c2001.
|
| 300 |
|
|
|a viii, 83 p.
|
| 500 |
|
|
|a Updates and replaces Guidelines for developing national drug policies, 1988.
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 650 |
|
0 |
|a Pharmaceutical policy.
|
| 710 |
2 |
|
|a ebrary, Inc.
|
| 856 |
4 |
0 |
|u http://site.ebrary.com/lib/ucy/Doc?id=10062381
|
| 952 |
|
|
|a CY-NiOUC
|b 5a04551d6c5ad14ac1ecb0d1
|c 998a
|d 945l
|e -
|t 1
|x m
|z Books
|
